Myoclonus

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 5, 2013, Pages 1264-1286

  Espay, Alberto J ^a   Chen, Robert ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; 5 HYDROXYTRYPTOPHAN; AMANTADINE; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CARBIDOPA PLUS LEVODOPA; CARNITINE; CLONAZEPAM; ENTACAPONE; ETIRACETAM; GLYCINE RECEPTOR; GLYCINE TRANSPORTER 2; LAMOTRIGINE; LEVODOPA; OXYBATE SODIUM; PETHIDINE; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PRAMIPEXOLE; PRIMIDONE; PROPRANOLOL; TETRABENAZINE; TOPIRAMATE; TYROSINE 3 MONOOXYGENASE; UBIDECARENONE; UNINDEXED DRUG; VALPROIC ACID; ZONISAMIDE;

ALZHEIMER DISEASE; BACTERIAL PNEUMONIA; BALANCE DISORDER; BEDTIME DOSAGE; BRAIN ATROPHY; CARDIOPULMONARY INSUFFICIENCY; CHOREA; CHROMOSOME; CHROMOSOME 7; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG EFFICACY; DYSTONIA; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; ESSENTIAL TREMOR; FASCICULATION; GAIT DISORDER; GENE MUTATION; HEMIBALLISM; HERPES ZOSTER OTICUS; HUMAN; HYPEREKPLEXIA; KIDNEY FAILURE; LANCE ADAMS SYNDROME; LATENT PERIOD; LIVEDO RETICULARIS; LUNG SMALL CELL CANCER; MYOCLONUS; MYOCLONUS DYSTONIA; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; MYOKYMIA; NEUROPATHOLOGY; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPSOCLONUS MYOCLONUS SYNDROME; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIMARY PROGRESSIVE APHASIA; REVIEW; SILVER RUSSELL SYNDROME; ST. LOUIS ENCEPHALITIS; SUSTAINED DRUG RELEASE; TENDON REFLEX; TIC; TREMOR; TYROSINE HYDROXYLASE DEFICIENCY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; DIAGNOSIS, DIFFERENTIAL; DYSTONIC DISORDERS; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; MALE; MYOCLONUS; NEURODEGENERATIVE DISEASES; RENAL INSUFFICIENCY;

EID: 84885648452     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000436156.54532.1a     Document Type: Review

References (53)

1. Shibasaki H, Kakigi R, Oda K, Masukawa S. Somatosensory and acoustic brain stem reflex myoclonus. J Neurol Neurosurg Psychiatry 1988;51(4):572-575.
2. Roze E, Bounolleau P, Ducreux D, et al. Propriospinal myoclonus revisited: clinical, neurophysiologic, and neuroradiologic findings. Neurology 2009;72(15):1301-1309.
3. van der Salm SM, Koelman JH, Henneke S, et al. Axial jerks: a clinical spectrum ranging from propriospinal to psychogenic myoclonus. J Neurol 2010;257(8):1349-1355.
4. Espay AJ, Ashby P, Hanajima R, et al. Unique form of propriospinal myoclonus as a possible complication of an enteropathogenic toxin. Mov Disord 2003;18(8):942-948. (Pubitemid 37021172)
5. Glass GA, Ahlskog JE, Matsumoto JY. Orthostatic myoclonus: a contributor to gait decline in selected elderly. Neurology 2007; 68(21):1826-1830. (Pubitemid 46791396)
6. Leu-Semenescu S, Roze E, Vidailhet M, et al. Myoclonus or tremor in orthostatism: an under-recognized cause of unsteadiness in Parkinson's disease. Mov Disord 2007;22(14): 2063-2069.
7. Espay AJ, Lang AE. Common movement disorders pitfalls: case-based teaching. New York, NY: Cambridge University Press, 2012.
8. Kinugawa K, Vidailhet M, Clot F, et al. Myoclonus-dystonia: an update. Mov Disord 2009;24(4):479-489.
9. Peall KJ, Waite AJ, Blake DJ, et al. Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: a systematic review. Mov Disord 2011;26(10):1939-1942.
10. Stamelou M, Mencacci NE, Cordivari C, et al. Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency. Neurology 2012;79(5):435-441.
11. Guettard E, Portnoi MF, Lohmann-Hedrich K, et al. Myoclonus-dystonia due to maternal uniparental disomy. Arch Neurol 2008;65(10):1380-1385.
12. Rajamani A, Seppelt I, Bourne J. Difficulties with neurological prognostication in a young woman with delayed-onset generalised status myoclonus after cardiac arrest due to acute severe asthma. Indian J Crit Care Med 2011;15(2):137-139.
13. Shin JH, Park JM, Kim AR, et al. Lance-adams syndrome. Ann Rehabil Med 2012;36(4): 561-564.
14. Stein R, Canny GJ, Bohn DJ, et al. Severe acute asthma in a pediatric intensive care unit: six years' experience. Pediatrics 1989; 83(6):1023-1028. (Pubitemid 19154680)
15. Defebvre L. Myoclonus and extrapyramidal diseases. Neurophysiol Clin 2006;36(5-6): 319-325.
16. Shafiq M, Lang AE. Myoclonus in parkinsonian disorders. Adv Neurol 2002;89:77-83.
17. Matsunaga K, Uozumi T, Akamatsu N, et al. Negative myoclonus in Creutzfeldt-Jakob disease. Clin Neurophysiol 2000;111(3): 471-476. (Pubitemid 30123117)
18. Gupta A, Lang AE. Drug-induced cranial myoclonus. Mov Disord 2010;25(13): 2264-2265.
19. Salazar G, Valls-Sole J, Marti MJ, et al. Postural and action myoclonus in patients with parkinsonian type multiple system atrophy. Mov Disord 2000;15(1):77-83. (Pubitemid 30037991)
20. Lou JS, Valls-Sole J, Toro C, Hallett M. Facial action myoclonus in patients with olivopontocerebellar atrophy. Mov Disord 1994;9(2):223-226. (Pubitemid 24092343)
21. Hu WT, Rippon GW, Boeve BF, et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 2009;24(9): 1375-1379.
22. Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013;80(5):496-503.
23. Blaes F, Fuhlhuber V, Korfei M, et al. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann Neurol 2005;58(2):313-317. (Pubitemid 41098889)
24. Dibbens LM, Michelucci R, Gambardella A, et al. SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure. Ann Neurol 2009;66(4):532-536.
25. Marsden CD, Harding AE, Obeso JA, Lu CS, et al. Progressive myoclonic ataxia (the Ramsay Hunt syndrome). Arch Neurol 1990;47(10):1121-1125. (Pubitemid 20326671)
26. Bhatia KP, Brown P, Gregory R, et al. Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain 1995;118(pt 5):1087-1093.
27. Ramachandran N, Girard JM, Turnbull J, Minassian BA. The autosomal recessively inherited progressive myoclonus epilepsies and their genes. Epilepsia 2009;50(suppl 5): 29-36.
28. Kousi M, Anttila V, Schulz A, et al. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene. J Med Genet 2012;49(6):391-399.
29. Vaamonde J, Muruzabal J, Tunon T, et al. Abnormal muscle and skin mitochondria in family with myoclonus, ataxia, and deafness (May and White syndrome). J Neurol Neurosurg Psychiatry 1992;55(2):128-132.
30. Pezzella M, Yeghiazaryan NS, Veggiotti P, et al. Galloway-Mowat syndrome: an early-onset progressive encephalopathy with intractable epilepsy associated to renal impairment. Two novel cases and review of literature. Seizure 2010;19(2):132-135.
31. Rubboli G, Franceschetti S, Berkovic SF, et al. Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations. Epilepsia 2011;52(12):2356-2363.
32. Brown P, Rothwell JC, Thompson PD, et al. The hyperekplexias and their relationship to the normal startle reflex. Brain 1991; 114(pt 4):1903-1928.
33. Tijssen MA, Vergouwe MN, van Dijk JG, et al. Major and minor form of hereditary hyperekplexia. Mov Disord 2002;17(4): 826-830. (Pubitemid 41295034)
34. James VM, Bode A, Chung SK, et al. Novel missense mutations in the glycine receptor beta subunit gene (GLRB) in startle disease. Neurobiol Dis 2013;52:137-149.
35. Carta E, Chung SK, James VM, et al. Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease. J Biol Chem 2012;287(34):28975- 28985.
36. Tanner CM, Chamberland J. Latah in Jakarta, Indonesia. Mov Disord 2001;16(3): 526-529. (Pubitemid 36041160)
37. Saint-Hilaire MH, Saint-Hilaire JM, Granger L. Jumping Frenchmen of Maine. Neurology 1986;36(9):1269-1271. (Pubitemid 16047016)
38. McFarling DA. The ''Ragin' Cajuns'' of Louisiana. Mov Disord 2001;16(3):531-532.
39. Brown P, Ridding MC, Werhahn KJ, et al. Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain 1996;119(pt 1):309-317. (Pubitemid 26077574)
40. Danner N, Saisanen L, Maatta S, et al. Motor cortical plasticity is impaired in Unverricht-Lundborg disease. Mov Disord 2011;26(11):2095-2100.
41. Chen R, Ashby P, Lang AE. Stimulus-sensitive myoclonus in akinetic-rigid syndromes. Brain 1992;115(pt 6):1875-1888. (Pubitemid 23054869)
42. van der Salm SM, Tijssen MA, Koelman JH, van Rootselaar AF. The bereitschaftspotential in jerky movement disorders. J Neurol Neurosurg Psychiatry 2012;83(12):1162-1167.
43. Gupta A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol 2009;22(4):430-436.
44. Frucht SJ, Houghton WC, Bordelon Y, et al. A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor. Neurology 2005;65(12):1967-1969.
45. Arpesella R, Dallocchio C, Arbasino C, et al. A patient with intractable posthypoxic myoclonus (Lance-Adams syndrome) treated with sodium oxybate. Anaesth Intensive Care 2009;37(2):314-318.
46. Awaad Y, Tayem H, Elgamal A, Coyne MF. Treatment of childhood myoclonus with botulinum toxin type A. J Child Neurol 1999;14(12):781-786. (Pubitemid 30035502)
47. Priori A, Bertolasi L, Pesenti A, et al. gamma-hydroxybutyric acid for alcohol-sensitive myoclonus with dystonia. Neurology 2000;54(8):1706.
48. Azoulay-Zyss J, Roze E, Welter ML, et al. Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to (-sarcoglycan mutations: a pilot study. Arch Neurol 2011;68(1):94-98.
49. Striano P, Manganelli F, Boccella P, et al. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. Mov Disord 2005;20(12):1610-1614.
50. DiMauro S, Hirano M. MERRF. In: Pagon RA, Bird TD, Dolan CR, et al, eds. GeneReviews Seattle, WA: University of Washington. Posted June 3, 2003. Updated August 18, 2009.
51. Chiodo AE, Saval A. Intrathecal baclofen for the treatment of spinal myoclonus: a case series. J Spinal Cord Med. 2012;35(1): 64-67.
52. Birthi P, Walters C, Ortiz Vargas O, Karandikar N. The use of intrathecal baclofen therapy for myoclonus in a patient with Lance Adams syndrome. PM R. 2011;3(7):671-673.
53. Hurd RW, Wilder BJ, Helveston WR, Uthman BM. Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine. Neurol. 1996;47(5): 1264-1268. (Pubitemid 26374898)